Stellaromics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$80M
- Investors
-
5
Stellaromics General Information
Description
Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. The company's tools use patented novel technology for identifying high-resolution three-dimensional transcription patterns in native biological tissue using hydrogel tissue chemistry, allowing researchers to conduct studies on thick tissue samples, and mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells.
Contact Information
Website
www.stellaromics.comCorporate Office
- 321 Harrison Avenue
- 5th Floor
- Boston, MA 02118
- United States
Corporate Office
- 321 Harrison Avenue
- 5th Floor
- Boston, MA 02118
- United States
Stellaromics Timeline
Stellaromics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 06-Dec-2024 | $80M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 02-Nov-2023 | Completed | Generating Revenue |
Stellaromics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | 3,581,779 | $0.000100 | $5.58 | $5.58 | 1x | $5.58 | 7.63% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Stellaromics Patents
Stellaromics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260092318-A1 | Methods, compositions, and systems for target detection in situ | Pending | 02-Aug-2024 | ||
| WO-2026030694-A2 | Methods, compositions, and systems for target detection in situ | Pending | 02-Aug-2024 | ||
| WO-2026030694-A3 | Methods, compositions, and systems for target detection in situ | Pending | 02-Aug-2024 | ||
| US-20260125743-A1 | Compositions and methods for target detection | Pending | 23-May-2024 | ||
| WO-2025245384-A1 | Compositions and methods for target detection | Pending | 23-May-2024 | G01N33/54306 |
Stellaromics Signals
Stellaromics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bayshore Global Management | Family Office | Minority | ||
| Catalyst4 | Venture Capital | Minority | ||
| Falcon Creek Capital | Venture Capital | Minority | ||
| Stanford University Venture Fund | Venture Capital | Minority | ||
| Plaisance Capital Management | Venture Capital | Minority |
Stellaromics FAQs
-
When was Stellaromics founded?
Stellaromics was founded in 2022.
-
Where is Stellaromics headquartered?
Stellaromics is headquartered in Boston, MA.
-
What is the size of Stellaromics?
Stellaromics has 49 total employees.
-
What industry is Stellaromics in?
Stellaromics’s primary industry is Discovery Tools (Healthcare).
-
Is Stellaromics a private or public company?
Stellaromics is a Private company.
-
What is the current valuation of Stellaromics?
The current valuation of Stellaromics is .
-
What is Stellaromics’s current revenue?
The current revenue for Stellaromics is .
-
How much funding has Stellaromics raised over time?
Stellaromics has raised $105M.
-
Who are Stellaromics’s investors?
Bayshore Global Management, Catalyst4, Falcon Creek Capital, Stanford University Venture Fund, and Plaisance Capital Management have invested in Stellaromics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process